PINNEBERG, DE / ACCESS Newswire / April 1, 2025 / Viromed Medical AG ("Viromed", ticker:VMED; ISIN:DE000A3MQR65), a medical technology company and pioneer of cold plasma technology for applications in ...
SAN FRANCISCO, CALIFORNIA / ACCESS Newswire / April 1, 2025 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or "the Company"), today announced the closing of its previously announced private ...
CHICAGO, IL AND ERIE, PA / ACCESS Newswire / April 1, 2025 / Aviva Aesthetics is proud to announce its latest partnership with iAesthetic Medspa, a premier medical aesthetics practice in Erie, ...
How Technology is Reshaping Aesthetic Medicine and Expanding Patient Options NEW YORK CITY, NY / ACCESS Newswire / April 1, 2025 / The field of cosmetic medicine is evolving at an unprecedented pace, ...
ORLANDO, FL / ACCESS Newswire / April 1, 2025 / MARIJUANA INC. (OTC PINK:MAJI), dba Exousia Pro, Inc., a clinical-stage biotech company using exosomes in the treatment of cancer and other maladies, is ...
Investment/MiscellaneousM1 Kliniken AG: HAEMATO AG is reviewing an offer for the sale of its trading segment01-Apr-2025 / 17:13 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of ...
Four Industry Veterans Unite to Replace Single-Use Plastics with High-Performance Pulp Products DAYTON, OHIO / ACCESS Newswire / April 1, 2025 / PulpFixin, a groundbreaking company dedicated to ...
Flexible PBM implements an AI-powered platform to reduce specialty drug costs while improving patient care. MILWAUKEE, WISCONSIN / ACCESS Newswire / April 1, 2025 / Serve You Rx, a full-service ...
SALT LAKE CITY, UTAH / ACCESS Newswire / April 1, 2025 / CenExel, a leading clinical research site network, has launched a new mobile application designed to make it easier for patients to find and ...
Company stands out in Ethics, Environment, and Labor and Human Rights focus areas for 2024 pls logo Pace Life Sciences logo ...
Company has one year of cash to fund operationsCompany advancing plans to develop TPI 287, a novel, late stage abeotaxane that is potentially blood brain barrier permeable with published clinical ...
Congress, Johnson & Johnson MedTech presented pivotal 12-month safety and effectiveness data from the SmartfIRE study—offering new insights into the future of atrial fibrillation (AFib) treatment. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results